Unilife Lodges S-1 Registration Statement With the SEC to Permit Resale of Shares Underlying Options

LEWISBERRY, Pa., June 21 /PRNewswire-FirstCall/ -- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS) wishes to advise that it has today lodged its Form S-1 resale registration statement with the United States Securities and Exchange Commission ("SEC").

Once declared effective by the SEC, the registration statement will remove restrictions which apply to the sale of shares issued to optionholders on exercise of their options. This will allow optionholders to freely trade those shares (other than affiliates of Unilife to which certain re-sale restrictions will still apply). The options to which this registration statement applies are the replacement Unilife Corporation options which were issued to optionholders upon the redomiciliation undertaken by the Unilife Group in January 2010.

The Company has filed this registration statement because under U.S. securities laws, the underlying shares issued, should these options be exercised, would be considered to be privately placed shares which could not be resold without a registration statement.

A copy of the Form S-1 resale registration statement can be viewed on the web via the following link: http://sec.gov/edgar/searchedgar/webusers.htm

The Company will update optionholders upon the registration statement being declared effective.

About Unilife Corporation

Unilife Corporation is a U.S.-based medical device company focused on the design, development, manufacture and supply of a proprietary range of retractable syringes. Primary target customers for Unilife products include pharmaceutical manufacturers, suppliers of medical equipment to healthcare facilities and patients who self-administer prescription medication. These patent-protected syringes incorporate automatic and fully-integrated safety features which are designed to protect those at risk of needlestick injuries and unsafe injection practices. Unilife is ISO 13485 certified and has FDA-registered medical device manufacturing facilities in Pennsylvania.

This press release contains forward-looking statements. All statements that address operating performance, events or developments that we expect or anticipate will occur in the future are forward-looking statements. These forward-looking statements are based on management's beliefs and assumptions and on information currently available to our management. Our management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in "Item 1A. Risk Factors" and elsewhere in our registration statement on Form 10 and those described from time to time in our periodic reports which we file with the Securities and Exchange Commission.  

General: UNIS-G

SOURCE Unilife Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED